Drugs / DASIPROTIMUT-T
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00091676 | Jan 2000 → Dec 2012 | non-Hodgkin lymphoma | Biovest International | Unknown | Mixed |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DASIPROTIMUT-T | ChEMBL registry synonym — accepted as the source's own label CHEMBL2364642 ↗ |
| Known as | BiovaxId | “BiovaxId, an autologous tumor derived immunoglobulin idiotype vaccine” NCT00091676 ↗ |
| Modality | Vaccine | “autologous tumor derived immunoglobulin idiotype vaccine” NCT00091676 ↗ |